CompletedNot Applicable

Identifying Risk Factors for Gram-negative Resistance for HAP/VAP in the Intensive Care Unit

United States132 participantsStarted 2020-06-30

Plain-language summary

Single center, retrospective chart review. Patients admitted to MDMC ICU from 4/1/2017 to 6/30/2020 will be identified through the electronic medical record utilizing ICD codes for HAP and VAP.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * ICU, Neuro critical care unit admission * Diagnosis of HAP or VAP * Respiratory culture positive for Gram-negative organism Exclusion Criteria: * ICU length of stay \<48 hours prior to HAP/VAP * Culture or MIC data unavailable * Pregnant

What they're measuring

Rate of Gram-negative isolate resistance to piperacillin-tazobactam, cefepime, meropenem

Timeframe: April 2017 - May 2020

Trial details

NCT IDNCT04700202

SponsorMethodist Health System

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2022-12-15

View on ClinicalTrials.gov More Ventilator-associated Pneumonia trials